US Patent Issued to The University of Tokyo, NEOPHARMA JAPAN on Feb. 24 for "Agent for ameliorating and/or preventing sickle cell disease" (Japanese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,333, issued on Feb. 24, was assigned to The University of Tokyo (Tokyo) and NEOPHARMA JAPAN Co. LTD. (Fukuroi, Japan).

"Agent for ameliorating and/or preventing sickle cell disease" was invented by Kenzaburo Tani (Tokyo), Yasushi Soda (Tokyo), Jiyuan Liao (Tokyo), Shohei Miyamoto (Tokyo), Satofumi Kawata (Tokyo), Motoyasu Tomioka (Tokyo) and Ken Kodama (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "An agent for ameliorating and/or preventing sickle cell disease, includes 5-aminolevulinic acid (ALA) or a derivative thereof or a salt thereof. The agent is useful for amelioration and/or prevention of sickle cell disease. The agent may include on...